Ticker
CSL
Analysis
Csl Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to CSL.
Csl Limited investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to CSL.
CSL
Stock
$36.27B
Health Technology
Biotechnology
AUD
Csl Limited may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
CSL Announces Delivery of MV Yampu MV Yampu departs on maiden voyage SYDNEY, June 12, 2026 (GLOBE NEWSWIRE) -- The CSL Group (“CSL”), a global leader in responsible marine trans...
CSL Announces Delivery of MV CSL Kuleana CSL Kuleana departs on maiden voyage Montreal, June 03, 2026 (GLOBE NEWSWIRE) -- On May 29, 2026, The CSL Group (CSL) took delivery of M...
CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario,
Vaccine Adjuvant Market is estimated to be valued at USD 1.81 Bn in 2026 and is expected to reach USD 2.13 Bn by 2033, growing CAGR of 2.34% from 2026 to 2033
CSL : Seqirus Signs Long-Term Agreement with the Pan American Health Organization (PAHO) to Advance Pandemic Influenza Preparedness in Latin America and the
Review valuation context for Csl Limited.
Review future growth context for Csl Limited.
Review past performance context for Csl Limited.
Review financial health context for Csl Limited.
Review dividend context for Csl Limited.
Review management context for Csl Limited.
Review ownership context for Csl Limited.
Review other information context for Csl Limited.
Review community context for Csl Limited.